Supernus, Inc. (INDV) stock
INDVNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SUPN
$35.37+0.12 (+0.34%)
Close on Oct 30, 2026Market cap $4.17BP/E 9.9Yield –
Supernus total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Supernus's total debt was $488.00M at Sep 30, 2026. For fiscal 2025 it was $319.00M, down 4.2% from the year before. The highest annual figure on record is $333.00M in fiscal 2024.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $319.00M | -4.2% |
| FY2024 | Dec 31, 2024 | $333.00M | +37.0% |
| FY2023 | Dec 31, 2023 | $243.00M | +1.2% |
| FY2022 | Dec 31, 2022 | $240.00M | -0.8% |
| FY2021 | Dec 31, 2021 | $242.00M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $488.00M | +51.6% |
| Q2 FY2026 | Jun 30, 2026 | $487.00M | +49.4% |
| Q1 FY2026 | Mar 31, 2026 | $486.00M | +47.7% |
| Q4 FY2025 | Dec 31, 2025 | $319.00M | -4.2% |
| Q3 FY2025 | Sep 30, 2025 | $322.00M | +32.5% |
| Q2 FY2025 | Jun 30, 2025 | $326.00M | +35.8% |
| Q1 FY2025 | Mar 31, 2025 | $329.00M | +36.0% |
| Q4 FY2024 | Dec 31, 2024 | $333.00M | – |
| Q4 FY2023 | Dec 31, 2023 | $243.00M | – |
| Q4 FY2022 | Dec 31, 2022 | $240.00M | – |
| Q4 FY2021 | Dec 31, 2021 | $242.00M | – |
See a number that looks wrong?